文献速递免疫规划妇幼与学校卫生卫生政策与健康促进

规划孕产妇免疫接种的未来:借鉴COVID-19大流行的经验

Planning for the future of maternal immunization: Building on lessons learned from the COVID-19 pandemic.
PubMed 文献 · Vaccine · 2024-02-29

本文总结COVID-19大流行期间孕产妇免疫接种的经验教训:孕妇感染后病情更重且妊娠结局更差,但疫苗预授权临床试验将孕妇排除,导致缺乏孕期安全性和有效性数据;疫苗安全担忧和不孕相关错误信息广泛传播,造成疫苗信心不足,初始接种率低;安全有效性数据公布后接种率上升,但疫苗接受度仍不理想且存在种族和民族差异。

要点

  • COVID-19大流行中孕妇感染后病情更严重且妊娠结局更差。
  • 疫苗预授权临床试验排除孕妇,导致孕期安全性和有效性数据缺乏。
  • 疫苗安全担忧和不孕相关错误信息广泛传播,造成疫苗信心不足。

核心结论

  • COVID-19大流行经验为当前和未来的孕产妇疫苗接种策略提供了宝贵见解。

研究设计与样本

  • 本文为综述,总结COVID-19大流行期间孕产妇免疫接种的经验教训。

主要发现

  • 孕妇感染SARS-CoV-2后病情更严重且妊娠结局更差。
  • COVID-19疫苗于2020年末上市时,因孕妇被排除在预授权临床试验之外,缺乏孕期使用的安全性和有效性数据。
  • 疫苗安全担忧和不孕相关错误信息广泛传播,造成疫苗信心不足。
  • 许多孕妇最初选择不接种疫苗;安全有效性数据公布后接种率上升,但COVID-19疫苗接受度仍不理想且存在种族和民族差异。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

As the worldwide COVID-19 pandemic unfolded, the clinical and public health community raced to understand SARS-CoV-2 infection and develop life-saving vaccines. Pregnant persons were disproportionately impacted, experiencing more severe illness and adverse pregnancy outcomes. And yet, when COVID-19 vaccines became available in late 2020, safety and efficacy data were not available to inform their use during pregnancy because pregnant persons were excluded from pre-authorization clinical trials. Concerns about vaccine safety during pregnancy and misinformation linking vaccination and infertility circulated widely, creating a lack of vaccine confidence. Many pregnant people initially chose not to get vaccinated, and while vaccination rates rose after safety and effectiveness data became available, COVID-19 vaccine acceptance was suboptimal and varied across racial and ethnic distribution of the pregnant population. The COVID-19 pandemic experience provided valuable insights that can inform current and future approaches to maternal vaccination against.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Meaney-Delman D, Carroll S, Polen K, et al. Planning for the future of maternal immunization: Building on lessons learned from the COVID-19 pandemic. Vaccine. 2024. PMID: 38423818. doi:10.1016/j.vaccine.2024.01.069

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。